SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-023869
Filing Date
2023-07-07
Accepted
2023-07-06 18:47:05
Documents
18
Period of Report
2023-07-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 51494
2 ex1-1.htm EX-1.1 326387
3 ex4-1.htm EX-4.1 164798
4 ex99-1.htm EX-99.1 23341
5 ex99-2.htm EX-99.2 27313
6 ex99-1_001.jpg GRAPHIC 2878
7 ex99-2_001.jpg GRAPHIC 11318
  Complete submission text file 0001493152-23-023869.txt   907018

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE vbiv-20230706.xsd EX-101.SCH 3024
9 XBRL LABEL FILE vbiv-20230706_lab.xml EX-101.LAB 34240
10 XBRL PRESENTATION FILE vbiv-20230706_pre.xml EX-101.PRE 22365
12 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3261
Mailing Address 160 SECOND STREET CAMBRIDGE CAMBRIDGE MA 02142
Business Address 160 SECOND STREET CAMBRIDGE CAMBRIDGE MA 02142 617-830-3031
VBI Vaccines Inc/BC (Filer) CIK: 0000764195 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37769 | Film No.: 231074831
SIC: 2834 Pharmaceutical Preparations